Close

Amarin (AMRN) Shakes Off Weakness, Sees Notable Upside

September 13, 2012 10:15 AM EDT
Shares of Amarin Corporation plc (NASDAQ: AMRN) are moving higher early Thursday, erasing a good chuck of the losses from earlier in the week after another NCE delay and some negative press about fish oil pills.

Many analysts have still been positive on the stock, and eventually NCE approval, despite the delay. One analyst suggested the FDA may be waiting for additional granted patents in order to legally support a decision to grant NCE and to fend off potential complaints by GlaxoSmithKline, the marketer of Lovaza.

Shares are up 4.6 percent ot $13.94 in early action.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Trader Talk